• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量银屑病关节炎的疾病活动度:在严格监测队列中实施 PASDAS 揭示了残余疾病负担。

Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.

机构信息

Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.

Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

Rheumatology (Oxford). 2021 Jul 1;60(7):3165-3175. doi: 10.1093/rheumatology/keaa766.

DOI:10.1093/rheumatology/keaa766
PMID:33331947
Abstract

OBJECTIVES

We aimed to investigate the disease activity and overall disease burden of (subgroups of) patients with PsA using the Psoriatic Arthritis Disease Activity Score (PASDAS) in an already tightly monitored cohort.

METHODS

This is a cross-sectional study evaluating data from the first visit of 855 PsA patients after implementation of the PASDAS in our tightly monitored cohort [e.g. DAS 28 (DAS28) was provided as an anchor]. Differences in clinical outcomes between subgroups of patients using established cut-offs for disease activity status [i.e. very low (VLDA), low (LDA), moderate (MDA), and high disease activity (HDA)] were examined.

RESULTS

Based on the PASDAS, 53.1% of patients were in VLDA/LDA. 29.5% of patients had ≥1 swollen joint, 20.6% had ≥1 enthesitis index point and 3.0% had active dactylitis. Based on DAS28, 77.5% of the patients were in VLDA/LDA. Patients reaching both DAS28 VLDA/LDA status and PASDAS VLDA/LDA status [N = 445 (52.0%)] were compared with patients reaching only DAS28 VLDA/LDA status [N = 218 (25.5%)]. For these latter patients, significantly worse scores on separate parameters were found in measures used for PASDAS/DAS28 calculation (e.g. swollen and tender joint count and patient's visual analogue scale global disease activity) as well as other disease measures (e.g. function and inflammatory back pain). This result remained, even when the stricter VLDA cut-off was used for the DAS28.

CONCLUSION

PASDAS implementation uncovered relevant residual disease activity in a quarter of patients previously assessed as being in DAS28 VLDA/LDA, underscoring the potential value of PASDAS measurements in PsA clinical care.

摘要

目的

我们旨在通过 PASDAS 评估已经接受严密监测的队列中(亚组)患者的疾病活动度和整体疾病负担。

方法

这是一项横断面研究,评估了在我们严密监测的队列中实施 PASDAS 后 855 例 PsA 患者首次就诊的数据[例如,DAS28(DAS28)作为锚定物]。使用疾病活动状态的既定切点评估亚组患者之间的临床结局差异[即极低疾病活动度(VLDA)、低疾病活动度(LDA)、中度疾病活动度(MDA)和高疾病活动度(HDA)]。

结果

根据 PASDAS,53.1%的患者处于 VLDA/LDA。29.5%的患者有≥1个肿胀关节,20.6%的患者有≥1个肌腱压痛指数点,3.0%的患者有活动性指(趾)炎。根据 DAS28,77.5%的患者处于 VLDA/LDA。达到 DAS28 VLDA/LDA 状态和 PASDAS VLDA/LDA 状态的患者[N=445(52.0%)]与仅达到 DAS28 VLDA/LDA 状态的患者[N=218(25.5%)]进行比较。对于这些后者患者,在用于 PASDAS/DAS28 计算的单独参数(例如肿胀和压痛关节计数以及患者的视觉模拟量表总体疾病活动度)以及其他疾病指标(例如功能和炎症性背痛)中发现了明显更差的评分。即使 DAS28 使用更严格的 VLDA 切点,结果仍然如此。

结论

在先前评估为 DAS28 VLDA/LDA 的患者中,有四分之一的患者通过 PASDAS 发现了明显的残余疾病活动,这突显了 PASDAS 测量在 PsA 临床护理中的潜在价值。

相似文献

1
Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.测量银屑病关节炎的疾病活动度:在严格监测队列中实施 PASDAS 揭示了残余疾病负担。
Rheumatology (Oxford). 2021 Jul 1;60(7):3165-3175. doi: 10.1093/rheumatology/keaa766.
2
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.在一项针对银屑病关节炎患者的临床试验环境中,使用 DAPSA、MDA 和 VLDA 比较缓解和低疾病活动状态:来自 FUTURE 2 研究的 2 年结果。
Semin Arthritis Rheum. 2020 Aug;50(4):709-718. doi: 10.1016/j.semarthrit.2020.03.015. Epub 2020 May 15.
3
Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?银屑病关节炎患者的残留症状和疾病负担:是否需要新的疾病活动指数?
Rheumatol Int. 2019 Jan;39(1):73-81. doi: 10.1007/s00296-018-4201-3. Epub 2018 Nov 13.
4
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.司库奇尤单抗可使银屑病关节炎患者持续达到 PASDAS 定义的缓解,并改善缓解患者的健康相关生活质量:来自 III 期 FUTURE 2 研究的 2 年结果。
Arthritis Res Ther. 2018 Dec 7;20(1):272. doi: 10.1186/s13075-018-1773-y.
5
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis.在依那西普和甲氨蝶呤单药或联合治疗银屑病关节炎的试验中使用的复合指标的表现。
Rheumatology (Oxford). 2021 Mar 2;60(3):1137-1147. doi: 10.1093/rheumatology/keaa271.
6
Evaluating current definitions of low disease activity in psoriatic arthritis using ultrasound.使用超声评估银屑病关节炎中低疾病活动度的现有定义。
Rheumatology (Oxford). 2019 Dec 1;58(12):2212-2220. doi: 10.1093/rheumatology/kez237.
7
Being overweight is associated with not reaching low disease activity in women but not men with psoriatic arthritis.超重与女性银屑病关节炎患者无法达到低疾病活动度相关,但与男性患者无关。
Rheumatology (Oxford). 2022 Feb 2;61(2):770-774. doi: 10.1093/rheumatology/keab338.
8
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies.银屑病关节炎患者的银屑病关节炎疾病活动指数(DAPSA)与最小疾病活动度(MDA)目标的比较:一项托法替布3期研究数据的事后分析
Semin Arthritis Rheum. 2023 Feb;58:152134. doi: 10.1016/j.semarthrit.2022.152134. Epub 2022 Nov 13.
9
Comparison of disease activity measures in early psoriatic arthritis in usual care.常规治疗下早期银屑病关节炎疾病活动度的比较。
Rheumatology (Oxford). 2019 Dec 1;58(12):2251-2259. doi: 10.1093/rheumatology/kez215.
10
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis.古塞单抗为活动性银屑病关节炎患者提供了基于复合指数的持续的、特定域和全面的疗效。
Rheumatology (Oxford). 2023 Feb 1;62(2):606-616. doi: 10.1093/rheumatology/keac375.

引用本文的文献

1
Sociodemographic factors and biologic therapy exposure impacting health-related quality of life in psoriatic arthritis - findings from a nationwide registry Reuma.pt.社会人口学因素和生物治疗暴露对银屑病关节炎患者健康相关生活质量的影响——来自全国性Reuma.pt登记处的研究结果
Sci Rep. 2025 Aug 13;15(1):29711. doi: 10.1038/s41598-025-14790-7.
2
Demographic Characteristics and Inflammatory Biomarker Profile in Psoriatic Arthritis Patients with Comorbid Fibromyalgia: A Cross-Sectional Study.合并纤维肌痛的银屑病关节炎患者的人口统计学特征和炎症生物标志物概况:一项横断面研究。
Medicina (Kaunas). 2025 Jun 6;61(6):1050. doi: 10.3390/medicina61061050.
3
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry.
司库奇尤单抗在不同临床表型银屑病关节炎中的疗效和保留率:来自意大利GISEA注册研究的见解
Ther Adv Musculoskelet Dis. 2025 Jan 31;17:1759720X251315138. doi: 10.1177/1759720X251315138. eCollection 2025.
4
Determinants of work and social participation in patients with psoriatic arthritis in the Netherlands: an observational study.荷兰银屑病关节炎患者工作和社会参与的决定因素:一项观察性研究。
BMC Rheumatol. 2022 Aug 17;6(1):49. doi: 10.1186/s41927-022-00279-7.
5
Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort.银屑病关节炎早期风湿科转诊的探索(DAPPER)研究:一项前瞻性观察性队列研究。
Acta Derm Venereol. 2022 Aug 26;102:adv00768. doi: 10.2340/actadv.v102.2225.
6
Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients.治疗达标理念在银屑病关节炎患者评估中的应用
J Clin Med. 2021 Nov 30;10(23):5659. doi: 10.3390/jcm10235659.